Tryton Medical, Inc. Announces DRG Reimbursement Code for Side Branch Stent in Germany
12/20/2011 10:49:45 AM
DURHAM, N.C.--(BUSINESS WIRE)--Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced that the German Institute for Medical Documentation and Information (DIMDI, Cologne) has revised the procedure code for the treatment of coronary bifurcations lesions, distinguishing dedicated side branch stent systems from conventional technique and providing for additional reimbursement for use of the Tryton side branch stent.
comments powered by